ADVISORY BOARD


FRANCESCO SANTO, DIRECTOR CLINICAL SUPPLY CHAIN, ORANO MED


A highly experienced and passionate director clinical supply chain, Francesco has dedicated the past 17 years to ensuring the seamless execution of clinical trials by optimising supply chain operations. His deep commitment to this field is driven by a relentless pursuit of excellence in delivering life-saving treatments to patients worldwide. Throughout his career, he has honed a diverse skill set, encompassing strategic supply chain management, regulatory compliance, cross-functional collaboration, risk management, and innovative problem-solving. Francesco’s dedication to the clinical supplies industry is rooted in a profound understanding of the critical


role it plays in advancing medical research and improving patient outcomes. He is committed to continuing his journey in this field, always striving to contribute to the betterment of global health.


ARNAUD DOURLENS, GLOBAL HEAD CLINICAL SUPPLY CHAIN OPERATIONS, SANOFI


Arnaud Dourlens is an Arts et Métiers engineer. He began his industrial career in the FMCG sector where he held growing responsibilities. Then he joined the LVMH group where he reorganised new product launches and industrial investments in the make-up segment in order to adapt to the need for innovation and time to market, thus providing a competitive advantage. He then managed the entire portfolio of industrial launches and investments in perfumes, skincare and make-up for Parfums Christian Dior Group.


During his career Arnaud held a wide variety of industrial roles. He joined Sanofi in 2017 as production


director of a major solid oral form production site (>€2.5bn turnover). He has been a key player in the development of the continuous improvement mindset and in the transformation of the site through IT projects, investments, and activity growth following the acquisition of Boehringer Ingelheim consumer healthcare portfolio. Since the beginning of 2020, he’s been the Global Head of Sanofi Clinical Supply Chain Operations, managing worldwide clinical supply teams involved in more than 300 clinical studies.


PAUL LAROCHELLE, DIRECTOR GLOBAL CLINICAL SUPPLY CHAIN PLANNING, TAKEDA


Paul Larochelle has over 17 years of experience in a variety of positions within Clinical Supplies, including roles in clinical planning, production scheduling and planning, secondary packaging operations management, and business expert for a clinical inventory management system. Paul currently leads a team of clinical planning leads at Takeda and is a member of the Global Clinical Supply Chain (GCSC) Leadership Team. He also oversees Takeda’s GCSC Post-PharmD Fellowship Program in partnership with the Massachusetts College of Pharmacy and Health Sciences (MCPHS). Paul’s prior organizations include Genzyme/Sanofi and Biogen, supporting therapies across all indications and stages of development. In addition to his primary responsibilities, Paul served as a coordinator of Pharmacy Industry Fellowships


for the Genzyme/Sanofi MCPHS Fellowship Program (2009-2014) and precepted over 50 pharmacy students interested in a career in industry for several schools. He is currently the Chair of the Dean’s Advisory Board for MCPHS Boston School of Pharmacy and a member of the Pharmacy Advisory Board for Western New England University. He is also a member of the Clinical Trial Supply Conference Series Advisory Board. Paul completed a Post-PharmD Industry Fellowship in Clinical Research/Investigational Product Management with Genzyme/MCPHS, a Doctorate in Pharmacy from MCPHS, an MBA from Worcester Polytechnic Institute, and a degree in Biology from Providence College. Paul has also served previously as President of the Board of Directors for the Massachusetts Pharmacists Association (MPhA), and as President of the MCPHS Alumni Association.


Clinical Trial Supply Handbook | 5


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44